✦ LIBER ✦

Direct healthcare costs of patients with type 2 diabetes using long-acting insulin analogues or NPH insulin in a basal insulin-only regimen

✍ Scribed by Jens Gundgaard; Torsten E. Christensen; Trine Lyager Thomsen

Book ID: 119344022
Publisher: Elsevier
Year: 2010
Tongue: English
Weight: 204 KB
Volume: 4
Category: Article
ISSN: 1751-9918
DOI: 10.1016/j.pcd.2010.04.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB17 THE HEALTH CARE COSTS OF LONG-ACTI

PDB17 THE HEALTH CARE COSTS OF LONG-ACTING INSULIN ANALOGS COMPARED WITH NPH INSULIN IN PATIENTS WITH TYPE 2 DIABETES USING A BASAL REGIMEN: A DANISH PERSPECTIVE

✍ J Gundgaard; T Christensen; TL Thomsen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PDB27 INSULIN GLARGINE AND NPH INSULIN-B

PDB27 INSULIN GLARGINE AND NPH INSULIN-BASED REGIMENS REVEAL COMPARABLE TOTAL DIRECT TREATMENT COSTS IN TYPE 2 DIABETES PATIENTS.THE LONG-ACTING INSULIN GLARGINE VS. NPH INSULIN COST EVALUATION STUDY IN GERMANY (LIVE-DE)

✍ T Scholten; R Holle; W Landgraf; A Spiesecke; H Hauner 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Increased insulin dose requirement of lo

Increased insulin dose requirement of long-acting insulin analogues in obese patients with type 2 diabetes

✍ C. Schmid; P. Krayenbühl; P. Wiesli 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 55 KB

A Randomized, Controlled Study of Once-D

A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type 2 Diabetes

✍ Bergenstal, R. M.; Rosenstock, J.; Arakaki, R. F.; Prince, M. J.; Qu, Y.; Sinha, 📂 Article 📅 2012 🏛 American Diabetes Association 🌐 English ⚖ 751 KB

PDB15 COMPARATIVE COST-UTILITY ANALYSIS

PDB15 COMPARATIVE COST-UTILITY ANALYSIS OF LONG-ACTING INSULIN ANALOGUE (INSULIN DETEMIR) AND NPH INSULIN FOR THE TREATMENT OF TYPE 1 AND TYPE 2 DIABETES AND THE BUDGET IMPACT ANALYSIS OF INSULIN ANALOGUE REIMBURSEMENT IN POLAND

✍ J Walczak; D Pawlik; A Jasinska; M Garbacka; J Kedzior; T Fundament; I Malczak; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PDB21 A COST COMPARISON OF A BASAL BOLUS

PDB21 A COST COMPARISON OF A BASAL BOLUS REGIMEN (INSULIN GLARGINE AND INSULIN GLULISINE) WITH A CONVENTIONAL PRE-MIXED INSULIN REGIMEN IN TYPE-2 DIABETES PATIENTS – THE GINGER STUDY

✍ C. Tilling; J. Vora; M. Keech 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB